Fuminori Sakurai
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 122 publications
Evaluation of transduction properties and vaccine efficacy of a simian adenovirus type 25-based vector.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 20, 2026
Association between the Risk of Drug-induced Liver Injury and the Reactive Metabolites Acyl Glucuronides
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: February 01, 2026
Oncolytic Reovirus-Induced Prostaglandin E2 Production in Human Tumor Cells.
Journal: Biological & pharmaceutical bulletin
Published: December 07, 2025
Effects of cellular receptors on the vaccine efficacies of adenovirus vector-based vaccines following intramuscular and intranasal administration.
Journal: Scientific reports
Published: September 30, 2025
Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation.
Journal: Molecular therapy. Advances
Published: September 18, 2025
Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation of antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: June 09, 2025
Evaluation of the correlation between nuclear localization levels and genome editing efficiencies of Cas12a fused with nuclear localization signals.
Journal: Journal of pharmaceutical sciences
Published: September 17, 2024
Small extracellular vesicles carrying reovirus, tumor antigens, interferon-β, and damage-associated molecular patterns for efficient tumor treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 25, 2023
Transplacental delivery of factor IX Fc-fusion protein ameliorates bleeding phenotype of newborn hemophilia B mice.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 22, 2023
Development of a novel adenovirus serotype 35 vector vaccine possessing an RGD peptide in the fiber knob and the E4 orf 4, 6, and 6/7 regions of adenovirus serotype 5.
Journal: International journal of pharmaceutics
Published: November 01, 2023
Last Updated: 09/26/2026